Skip to Content Skip to Content

Health Sciences

Reset All Filters
2001 Results
Marcus Henderson and Ian McCurry of Penn to Connect Homeless With Health Care

Marcus Henderson and Ian McCurry of Penn to Connect Homeless With Health Care

A Google search back in 2013 started things off. Typing in “Philadelphia,” “homeless” and “church,” Ian McCurry, then a freshman in the University of Pennsylvania’s School of Nursing, found a way to reach out to a vulnerable community that he could assist and support using his growing knowledge of health care.

Katherine Unger Baillie

Two at Penn Honored by National Minority Quality Forum

Two at Penn Honored by National Minority Quality Forum

Two members of the University of Pennsylvania community have been named recipients of the National Minority Quality Forum’s 40 Under 40 Leaders in Minority Health Award, recognizing young minority thought leaders who are working to reduce health-c

Jacquie Posey , John Infanti

Penn Study: Clinical Trial Shows Benefit of Yoga for Side Effects of Prostate Cancer Treatment

Penn Study: Clinical Trial Shows Benefit of Yoga for Side Effects of Prostate Cancer Treatment

Men who attended a structured yoga class twice a week during prostate cancer radiation treatment reported less fatigue and better sexual and urinary function than those who didn’t, according to a clinical trial led by the Perelman School of Medicine at the University of Pennsylvania.

John Infanti

Penn Psychologists Find Photos, Videos Result in Similar Understanding of Actions

Penn Psychologists Find Photos, Videos Result in Similar Understanding of Actions

Viewing an action — for example, biting or kicking or punching — in a photo versus a video doesn’t change the understanding of what’s taking place, according to new research from University of Pennsylvania psychologists Russell Epstein,

Michele W. Berger

Penn Researchers Use New Imaging to Show Key Enzyme in Ovarian Cancer

Penn Researchers Use New Imaging to Show Key Enzyme in Ovarian Cancer

A new imaging test may provide the ability to identify ovarian cancer patients who are candidates for an emerging treatment that targets a key enzyme cancer cells need to survive. Currently, epithelial ovarian cancer patients with BRCA1 mutations are considered candidates for the treatment, but there is no method to measure the enzyme levels to help guide treatment choices.

John Infanti